A Screen of 1,049 Schizophrenia and 30 Alzheimer's-associated Variants for Regulatory Potential

Overview

Journal Am J Med Genet B Neuropsychiatr Genet

Specialties Genetics
Neurology
Psychiatry

Date 2019 Sep 11

PMID 31503409

Citations 24

Authors

Leslie Myint

Ruihua Wang

Leandros Boukas

Kasper D Hansen

Loyal A Goff

Dimitrios Avramopoulos

Affiliations

Soon will be listed here.

Abstract

Recent genome-wide association studies (GWAS) identified numerous schizophrenia (SZ) and Alzheimer's disease (AD) associated loci, most outside protein-coding regions and hypothesized to affect gene transcription. We used a massively parallel reporter assay to screen, 1,049 SZ and 30 AD variants in 64 and nine loci, respectively for allele differences in driving reporter gene expression. A library of synthetic oligonucleotides assaying each allele five times was transfected into K562 chronic myelogenous leukemia lymphoblasts and SK-SY5Y human neuroblastoma cells. One hundred forty eight variants showed allelic differences in K562 and 53 in SK-SY5Y cells, on average 2.6 variants per locus. Nine showed significant differences in both lines, a modest overlap reflecting different regulatory landscapes of these lines that also differ significantly in chromatin marks. Eight of nine were in the same direction. We observe no preference for risk alleles to increase or decrease expression. We find a positive correlation between the number of SNPs in linkage disequilibrium and the proportion of functional SNPs supporting combinatorial effects that may lead to haplotype selection. Our results prioritize future functional follow up of disease associated SNPs to determine the driver GWAS variant(s), at each locus and enhance our understanding of gene regulation dynamics.

Citing Articles

Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits.

Wan J, van Ouwerkerk A, Mouren J, Heredia C, Pradel L, Ballester B Nucleic Acids Res. 2024; 53(4).

PMID: 39727170 PMC: 11879118. DOI: 10.1093/nar/gkae1270.

Just a SNP away: The future of massively parallel reporter assay.

Degner K, Bell J, Jones S, Won H Cell Insight. 2024; 4(1):100214.

PMID: 39618480 PMC: 11607654. DOI: 10.1016/j.cellin.2024.100214.

Identification, Design, and Application of Noncoding Cis-Regulatory Elements.

Xu L, Liu Y Biomolecules. 2024; 14(8).

PMID: 39199333 PMC: 11352686. DOI: 10.3390/biom14080945.

High-throughput assays to assess variant effects on disease.

Ma K, Gauthier L, Cheung F, Huang S, Lek M Dis Model Mech. 2024; 17(6).

PMID: 38940340 PMC: 11225591. DOI: 10.1242/dmm.050573.

Advances in computational and experimental approaches for deciphering transcriptional regulatory networks: Understanding the roles of cis-regulatory elements is essential, and recent research utilizing MPRAs, STARR-seq, CRISPR-Cas9, and machine....

Moeckel C, Mouratidis I, Chantzi N, Uzun Y, Georgakopoulos-Soares I Bioessays. 2024; 46(7):e2300210.

PMID: 38715516 PMC: 11444527. DOI: 10.1002/bies.202300210.

References

Castel S, Cervera A, Mohammadi P, Aguet F, Reverter F, Wolman A . Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat Genet. 2018; 50(9):1327-1334. PMC: 6119105. DOI: 10.1038/s41588-018-0192-y. View

Hindorff L, Sethupathy P, Junkins H, Ramos E, Mehta J, Collins F . Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009; 106(23):9362-7. PMC: 2687147. DOI: 10.1073/pnas.0903103106. View

Visel A, Rubin E, Pennacchio L . Genomic views of distant-acting enhancers. Nature. 2009; 461(7261):199-205. PMC: 2923221. DOI: 10.1038/nature08451. View

Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L, Rogov P . Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat Biotechnol. 2012; 30(3):271-7. PMC: 3297981. DOI: 10.1038/nbt.2137. View

Manolio T, Collins F, Cox N, Goldstein D, Hindorff L, Hunter D . Finding the missing heritability of complex diseases. Nature. 2009; 461(7265):747-53. PMC: 2831613. DOI: 10.1038/nature08494. View

Wu J, Wang X, Beveridge N, Tooney P, Scott R, Carr V . Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One. 2012; 7(4):e36351. PMC: 3338678. DOI: 10.1371/journal.pone.0036351. View

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

Visscher P, Wray N, Zhang Q, Sklar P, McCarthy M, Brown M . 10 Years of GWAS Discovery: Biology, Function, and Translation. Am J Hum Genet. 2017; 101(1):5-22. PMC: 5501872. DOI: 10.1016/j.ajhg.2017.06.005. View

Inoue F, Ahituv N . Decoding enhancers using massively parallel reporter assays. Genomics. 2015; 106(3):159-164. PMC: 4540663. DOI: 10.1016/j.ygeno.2015.06.005. View

10.

Kfir N, Lev-Maor G, Glaich O, Alajem A, Datta A, Sze S . SF3B1 association with chromatin determines splicing outcomes. Cell Rep. 2015; 11(4):618-29. DOI: 10.1016/j.celrep.2015.03.048. View

11.

Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

12.

Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M . Mapping complex disease traits with global gene expression. Nat Rev Genet. 2009; 10(3):184-94. PMC: 4550035. DOI: 10.1038/nrg2537. View

13.

Myint L, Avramopoulos D, Goff L, Hansen K . Linear models enable powerful differential activity analysis in massively parallel reporter assays. BMC Genomics. 2019; 20(1):209. PMC: 6417258. DOI: 10.1186/s12864-019-5556-x. View

14.

Kheradpour P, Ernst J, Melnikov A, Rogov P, Wang L, Zhang X . Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res. 2013; 23(5):800-11. PMC: 3638136. DOI: 10.1101/gr.144899.112. View

15.

Johnson A, Handsaker R, Pulit S, Nizzari M, ODonnell C, de Bakker P . SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008; 24(24):2938-9. PMC: 2720775. DOI: 10.1093/bioinformatics/btn564. View

16.

Liedtke E, Zhang S, Thompson J, Sillau S, Gault J . Correlated expression analysis of genes implicated in schizophrenia: identification of putative disease-related pathways. New Horiz Transl Med. 2020; 3(5):224-232. PMC: 7454191. View

17.

Eckart N, Song Q, Yang R, Wang R, Zhu H, McCallion A . Functional Characterization of Schizophrenia-Associated Variation in CACNA1C. PLoS One. 2016; 11(6):e0157086. PMC: 4898738. DOI: 10.1371/journal.pone.0157086. View

18.

. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View

19.

Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Cowper-Sal Lari R . Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 2013; 24(1):1-13. PMC: 3875850. DOI: 10.1101/gr.164079.113. View

20.

Pardinas A, Holmans P, Pocklington A, Escott-Price V, Ripke S, Carrera N . Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018; 50(3):381-389. PMC: 5918692. DOI: 10.1038/s41588-018-0059-2. View